Literature DB >> 15734693

Co-infection of Mycobacterium tuberculosis and Mycobacterium leprae in human archaeological samples: a possible explanation for the historical decline of leprosy.

Helen D Donoghue1, Antónia Marcsik, Carney Matheson, Kim Vernon, Emilia Nuorala, Joseph E Molto, Charles L Greenblatt, Mark Spigelman.   

Abstract

Both leprosy and tuberculosis were prevalent in Europe during the first millennium but thereafter leprosy declined. It is not known why this occurred, but one suggestion is that cross-immunity protected tuberculosis patients from leprosy. To investigate any relationship between the two diseases, selected archaeological samples, dating from the Roman period to the thirteenth century, were examined for both Mycobacterium leprae and Mycobacterium tuberculosis DNA, using PCR. The work was carried out and verified in geographically separate and independent laboratories. Several specimens with palaeopathological signs of leprosy were found to contain DNA from both pathogens, indicating that these diseases coexisted in the past. We suggest that the immunological changes found in multi-bacillary leprosy, in association with the socio-economic impact on those suffering from the disease, led to increased mortality from tuberculosis and therefore to the historical decline in leprosy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734693      PMCID: PMC1634979          DOI: 10.1098/rspb.2004.2966

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  22 in total

Review 1.  The role of Toll-like receptors in combating mycobacteria.

Authors:  Stephan R Krutzik; Robert L Modlin
Journal:  Semin Immunol       Date:  2004-02       Impact factor: 11.130

2.  The global tuberculosis situation and the new control strategy of the World Health Organization.

Authors:  A Kochi
Journal:  Tubercle       Date:  1991-03

3.  Autopsy findings in 35 cases of leprosy in Malaysia.

Authors:  P Jayalakshmi; L M Looi; K J Lim; K Rajogopalan
Journal:  Int J Lepr Other Mycobact Dis       Date:  1987-09

Review 4.  Leprosy and tuberculosis--an epidemiological comparison.

Authors:  P Fine
Journal:  Tubercle       Date:  1984-06

5.  An estimate of the contribution of HIV infection to the recent rise in tuberculosis in England and Wales.

Authors:  A M C Rose; K Sinka; J M Watson; J Y Mortimer; A Charlett
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

Review 6.  Iron, mycobacteria and tuberculosis.

Authors:  Colin Ratledge
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

7.  The association of leprosy and pulmonary tuberculosis.

Authors:  P Nigam; A L Dubey; S G Dayal; B M Goyal; H N Saxena; K C Samuel
Journal:  Lepr India       Date:  1979-01

Review 8.  Dimensions and process of stigmatization in leprosy.

Authors:  K A Bainson; B Van den Borne
Journal:  Lepr Rev       Date:  1998-12       Impact factor: 0.537

9.  Tuberculosis in leprosy patients detected between 1902 and 1991 in French Polynesia.

Authors:  P Glaziou; J L Cartel; J P Moulia-Pelat; L N Ngoc; S Chanteau; R Plichart; J H Grosset
Journal:  Int J Lepr Other Mycobact Dis       Date:  1993-06

10.  Concomitant occurrence of leprosy and tuberculosis--a clinical, bacteriological and radiological evaluation.

Authors:  B Kumar; S Kaur; S Kataria; S N Roy
Journal:  Lepr India       Date:  1982-10
View more
  36 in total

1.  Comment. Pathogenic microbial ancient DNA: a problem or an opportunity?

Authors:  Helen D Donoghue; Mark Spigelman
Journal:  Proc Biol Sci       Date:  2006-03-22       Impact factor: 5.349

2.  Evaluating bacterial pathogen DNA preservation in museum osteological collections.

Authors:  Ian Barnes; Mark G Thomas
Journal:  Proc Biol Sci       Date:  2006-03-22       Impact factor: 5.349

Review 3.  Mycobacterium leprae: genes, pseudogenes and genetic diversity.

Authors:  Pushpendra Singh; Stewart T Cole
Journal:  Future Microbiol       Date:  2011-01       Impact factor: 3.165

4.  Coinfection of leprosy and tuberculosis.

Authors:  Seema Shetty; Shashikiran Umakanth; Bhawani Manandhar; Pankaj Bahadur Nepali
Journal:  BMJ Case Rep       Date:  2018-03-15

5.  Concomittant pulmonary tuberculosis and borderline leprosy with type-II lepra reaction in single patient.

Authors:  Rajendra Prasad; Sanjay Kumar Verma; Rajni Singh; Giridhar Hosmane
Journal:  Lung India       Date:  2010-01

6.  Detection of Mycobacterium leprae DNA from archaeological skeletal remains in Japan using whole genome amplification and polymerase chain reaction.

Authors:  Koichi Suzuki; Wataru Takigawa; Kazunari Tanigawa; Kazuaki Nakamura; Yuko Ishido; Akira Kawashima; Huhehasi Wu; Takeshi Akama; Mariko Sue; Aya Yoshihara; Shuichi Mori; Norihisa Ishii
Journal:  PLoS One       Date:  2010-08-26       Impact factor: 3.240

Review 7.  Leprosy and tuberculosis co-infection: clinical and immunological report of two cases and review of the literature.

Authors:  Maria Ângela B Trindade; Denise Miyamoto; Gil Benard; Neusa Y Sakai-Valente; Dewton de M Vasconcelos; Bernard Naafs
Journal:  Am J Trop Med Hyg       Date:  2012-12-03       Impact factor: 2.345

8.  Ancient skeletal evidence for leprosy in India (2000 B.C.).

Authors:  Gwen Robbins; V Mushrif Tripathy; V N Misra; R K Mohanty; V S Shinde; Kelsey M Gray; Malcolm D Schug
Journal:  PLoS One       Date:  2009-05-27       Impact factor: 3.240

9.  Molecular exploration of the first-century Tomb of the Shroud in Akeldama, Jerusalem.

Authors:  Carney D Matheson; Kim K Vernon; Arlene Lahti; Renee Fratpietro; Mark Spigelman; Shimon Gibson; Charles L Greenblatt; Helen D Donoghue; Boaz Zissu
Journal:  PLoS One       Date:  2009-12-16       Impact factor: 3.240

10.  Tuberculosis in Dr Granville's mummy: a molecular re-examination of the earliest known Egyptian mummy to be scientifically examined and given a medical diagnosis.

Authors:  Helen D Donoghue; Oona Y-C Lee; David E Minnikin; Gurdyal S Besra; John H Taylor; Mark Spigelman
Journal:  Proc Biol Sci       Date:  2009-09-30       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.